首页> 外文期刊>Resuscitation. >Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR).
【24h】

Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR).

机译:在院前阶段已被诊断为ST段抬高型心肌梗死的患者的再灌注率和院内死亡率:德国院前心肌梗死登记处(PREMIR)的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

AIMS: We sought to evaluate the in-hospital fate of patients with ST segment elevation myocardial infarction (STEMI) diagnosed already in the prehospital phase by physican equipped ambulances. METHODS: A total of 2326 consecutive STEMI patients were included in PREMIR. For this analysis 218 patients with prehospital cardiopulmonary resuscitation were excluded. RESULTS: The median time between symptom onset and 12-lead ECG was 85 min. The median time intervals between the diagnostic 12-lead ECG and prehospital fibrinolysis were 10 min, until inhospital fibrinolysis 52 min and until primar PCI 86min, respectively. Reperfusion therapy with prehospital fibrinolysis (24%), inhospital fibrinolysis (13%) or primary PCI (45%) was performed in 82% of the patients. Inhospital mortality was 6.0% in patients with prehospital fibrinolysis (n = 504), 5.8% in patients with inhospital fibrinolysis (n = 278), 4.5% in patients with primary percutaneous coronary intervention (n = 962) and 16.2% in patients without early reperfusion therapy (n = 377), respectively. In the multivariate propensity score analysis comparing prehospital fibrinolysis and primary PCI we observed no significant difference in the odds for in-hospital mortality (odds ratio: 1.57, 95% CI: 0.94-2.63). The final discharge diagnosis was STEMI in 90% of the patients, in patients with prehospital fibrinolysis 95%. CONCLUSIONS: In patients with STEMI already diagnosed in the prehospital phase the ischemic time is short, accuracy of the diagnosis is high and reperfusion therapy is performed in over 82%. Inhospital mortality was not different between prehospital fibrinolysis and primary PCI.
机译:目的:我们试图评估配备物理救护车的ST段抬高型心肌梗死(STEMI)患者在院前阶段已被诊断出的院内命运。方法:总共2326例连续STEMI患者被纳入PREMIR。这项分析排除了218例院前心肺复苏患者。结果:症状发作和12导联心电图之间的中位时间为85分钟。诊断性12导联心电图和院前纤维蛋白溶解之间的中位时间间隔分别为10分钟,直到院内纤维蛋白溶解52分钟和直到原发性PCI 86分钟。 82%的患者接受了院前纤维蛋白溶解(24%),院内纤维蛋白溶解(13%)或原发性PCI(45%)的再灌注治疗。院前纤维蛋白溶解患者(n = 504)的院内死亡率为6.0%,院内纤维蛋白溶解患者(n = 278)的院内死亡率为5.8%,原发性经皮冠状动脉介入治疗的患者(n = 962)为4.5%,未进行早期早期治疗的患者为16.2%再灌注疗法(n = 377)。在比较院前纤维蛋白溶解和原发性PCI的多因素倾向评分分析中,我们观察到院内死亡率的几率无显着差异(赔率:1.57,95%CI:0.94-2.63)。最终出院诊断为STEMI的患者为90%,院前纤维蛋白溶解的患者为95%。结论:在院前期已被诊断为STEMI的患者中,缺血时间短,诊断准确度高且超过82%的患者进行了再灌注治疗。院前纤溶和原发性PCI之间院内死亡率无差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号